Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aimei Health Technology (AFJK) Enterprise Value (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Enterprise Value data on record, last reported at -$2979.0 in Q3 2025.

  • On a quarterly basis, Enterprise Value rose 97.12% to -$2979.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2979.0, a 97.12% increase, with the full-year FY2024 number at -$28208.0, up 95.14% from a year prior.
  • Enterprise Value reached -$2979.0 in Q3 2025 per AFJK's latest filing, up from -$7345.0 in the prior quarter.
  • Over the last five years, Enterprise Value for AFJK hit a ceiling of -$2979.0 in Q3 2025 and a floor of -$580717.0 in Q4 2023.
  • A 3-year average of -$184865.7 and a median of -$103559.0 in 2024 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: surged 95.14% in 2024, then soared 98.22% in 2025.
  • Tracing AFJK's Enterprise Value over 3 years: stood at -$580717.0 in 2023, then soared by 95.14% to -$28208.0 in 2024, then skyrocketed by 89.44% to -$2979.0 in 2025.
  • Business Quant data shows Enterprise Value for AFJK at -$2979.0 in Q3 2025, -$7345.0 in Q1 2025, and -$28208.0 in Q4 2024.